Choi Kyu-Won, Kim Ki-Ho, Kim Young-Hun
Department of Dermatology, College of Medicine, Dong-A University, Busan, Korea.
Ann Dermatol. 2009 May;21(2):136-41. doi: 10.5021/ad.2009.21.2.136. Epub 2009 May 31.
Determination of the minimal erythema dose (MED) is important for developing a phototherapy protocol and to diagnosis photosensitivity disorders. But obtaining a precise and reproducible MED is quite difficult because a phototest for erythema is based on subjective assessment.
The objective of our study was to compare the gross interpretation of a phototest and the objective measurement using a spectrophotometer for determining the parameters of cutaneous narrow-band UVB (NBUVB) therapy.
A total of 14 psoriasis and 10 vitiligo patients who receiving NBUVB phototherapy with skin types III and IV were selected for this study. To perform phototesting, ten sites on the skin of the back were vertically exposed to a series of 10 NBUVB doses among 14 doses between 340 and 1,400 mJ/cm(2). We interpreted the gross findings of erythema and measured the Lab* values with using a spectrophotometer at each phototest spot and at the control skin. Also, we evaluate the relationship between the gross presentation and the spectrophotometric analysis by delta E for the assessment of the minimal perceptible erythema (MPE) and MED.
For all the subjects, the MEDs were measured in the 4901,000 mJ/cm(2) range. The average of the colorimetric values for the control skin were L*: 64.8, a*: 7.9 and b*: 19.8. Among them, the L* value and MED value were shown to be inversely correlated, and as the L* value was decreased, the MED was increased. For the MPE, the delta E, which was the color difference of the normal skin and the phototest area, was within the range of 1.53.0 in 17 of the 21 patients, and 4 patients were within the range of 1.01.5. For the MED, among the 21 patients, the delta E of 17 patients was within the range of 3.06.0, and 4 patients were within the range of 6.0~12.0.
A spectrophotometer enables UV erythema to be assessed objectively and quantitatively, and this can compensate for the disadvantages of subjective gross interpretation when determining the MED. Delta E is a good novel and objective indicator for determining the MPE and MED. So, a spectrophotometer is a very useful instrument for developing a phototherapy protocol for psoriasis and other dermatoses and for making the diagnosis of photosensitivity disorders.
确定最小红斑量(MED)对于制定光疗方案和诊断光敏性疾病很重要。但由于红斑光试验基于主观评估,因此获得精确且可重复的MED相当困难。
我们研究的目的是比较光试验的总体判读与使用分光光度计进行客观测量,以确定皮肤窄谱中波紫外线(NBUVB)治疗的参数。
本研究共选取了14例银屑病患者和10例白癜风患者,他们均接受III型和IV型皮肤的NBUVB光疗。为进行光试验,背部皮肤上的10个部位垂直暴露于340至1400 mJ/cm²之间的14个剂量中的一系列10个NBUVB剂量下。我们判读红斑的总体表现,并在每个光试验部位和对照皮肤处使用分光光度计测量Lab*值。此外,我们通过ΔE评估总体表现与分光光度分析之间的关系,以评估最小可察觉红斑(MPE)和MED。
对于所有受试者,MED测量值在4901000 mJ/cm²范围内。对照皮肤的比色值平均值为L*:64.8,a*:7.9,b*:19.8。其中,L值与MED值呈负相关,随着L值降低,MED增加。对于MPE,正常皮肤与光试验区域的色差ΔE在21例患者中的17例处于1.53.0范围内,4例患者处于1.01.5范围内。对于MED,在21例患者中,17例患者的ΔE在3.06.0范围内,4例患者在6.0~12.0范围内。
分光光度计能够客观、定量地评估紫外线红斑,这可以弥补在确定MED时主观总体判读的缺点。ΔE是确定MPE和MED的一个很好的新型客观指标。因此,分光光度计是制定银屑病和其他皮肤病光疗方案以及诊断光敏性疾病的非常有用的仪器。